Shannon Nicole Goines, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 401 Southcrest Cir Ste 203, Southaven, MS 38671 Phone: 901-227-9580 Fax: 901-227-9527 |
Paula R Miller, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3451 Goodman Rd E Ste 115, Southaven, MS 38672 Phone: 662-890-5555 Fax: 662-890-8899 |
Samantha Shorter Vickrey, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 3451 Goodman Rd E Ste 115, Southaven, MS 38672 Phone: 662-890-5555 |
Ms. Dana Faith Gilbert, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 3495 Cobblestone Blvd S, Southaven, MS 38672 Phone: 662-892-2885 Fax: 662-890-1551 |
Tiffany Boyd, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1161 Church Road W, Southaven, MS 38671 Phone: 662-253-1067 Fax: 662-253-1068 |
Kimberly Rochelle Brown Tucker, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Parkway, Southaven, MS 38671 Phone: 662-772-2980 Fax: 662-772-2960 |
News Archive
Acute heart attacks can be successfully treated through a multidisciplinary team approach involving Emergency Medical Services, emergency physicians, cardiologists and specialty centres, according to a study conducted by Dr. Jacobus S. de Villiers and colleagues in Calgary.
A recent study by researchers from the University of Colorado looked at post-transplant care to determine whether primary care physicians (PCPs) or hepatologists are better suited to manage the overall health care of patients who received a liver transplant (LT).
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERIDĀ® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
Velano Vascular, a medical technology company transforming and enhancing the care experience for hospitalized patients and their practitioners, announced today that the company received U.S. Food and Drug Administration clearance for a modified version of its novel, needle-free blood draw device.
As the 16th anniversary of Hurricane Katrina on Aug. 29 approached, New Orleans residents were bracing for another disaster, Hurricane Ida. This year, similar to last, the country will be hit by an above-average number of extreme weather events, including major hurricanes, flooding, and wildfires.
› Verified 2 days ago